title: Establishment of a new human pneumococcal standard reference serum, 007sp.
abstract: Lot 89SF has been the reference standard serum pool used in pneumococcal enzyme-linked immunosorbent assays (ELISAs) since 1990. In 2005, it was estimated that there remained between 2 and 5 years' supply of lot 89SF. Since lot 89SF was the reference standard used in the evaluation of the seven-valent pneumococcal conjugate vaccine Prevnar (PCV7), the link to clinical efficacy would be severed if stocks became completely depleted. Furthermore, demonstration of immune responses comparable to those elicited by PCV7 is a licensure approach used for new pneumococcal conjugate vaccines, so a replacement reference standard was required. A total of 278 volunteers were immunized with the 23-valent unconjugated polysaccharide vaccine Pneumovax II, and a unit of blood was obtained twice within 120 days following immunization. Plasma was prepared, pooled, and confirmed to be free from hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV. The pooled serum was poured at 6 ml per vial into 15,333 vials and lyophilized. Immunological bridging of 007sp to 89SF was used to establish equivalent reference values for 13 pneumococcal capsular serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) by five independent laboratories. Antibody concentrations in 007sp were established relative to the lot 89SF reference preparation using the WHO reference ELISA. Subsequently, 12 existing WHO calibration sera had concentrations reassigned for 13 pneumococcal serotypes using new serum 007sp as the reference, and these were compared to concentrations relative to the original reference serum. Agreement was excellent for the 12 WHO calibration sera. The 007sp preparation has replaced 89SF as the pneumococcal reference standard. Sufficient quantity of this new preparation is available such that, with judicious use, it should be available for at least 25 years.
authors.affiliation: University College London, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. d.goldblatt@ich.ucl.ac.uk
authors.forename: D
authors.initials: D
authors.lastname: Goldblatt
authors.forename: B D
authors.initials: BD
authors.lastname: Plikaytis
authors.forename: M
authors.initials: M
authors.lastname: Akkoyunlu
authors.forename: J
authors.initials: J
authors.lastname: Antonello
authors.forename: L
authors.initials: L
authors.lastname: Ashton
authors.forename: M
authors.initials: M
authors.lastname: Blake
authors.forename: R
authors.initials: R
authors.lastname: Burton
authors.forename: R
authors.initials: R
authors.lastname: Care
authors.forename: N
authors.initials: N
authors.lastname: Durant
authors.forename: I
authors.initials: I
authors.lastname: Feavers
authors.forename: P
authors.initials: P
authors.lastname: Fernsten
authors.forename: F
authors.initials: F
authors.lastname: Fievet
authors.forename: P
authors.initials: P
authors.lastname: Giardina
authors.forename: K
authors.initials: K
authors.lastname: Jansen
authors.forename: L
authors.initials: L
authors.lastname: Katz
authors.forename: L
authors.initials: L
authors.lastname: Kierstead
authors.forename: L
authors.initials: L
authors.lastname: Lee
authors.forename: J
authors.initials: J
authors.lastname: Lin
authors.forename: J
authors.initials: J
authors.lastname: Maisonneuve
authors.forename: M H
authors.initials: MH
authors.lastname: Nahm
authors.forename: J
authors.initials: J
authors.lastname: Raab
authors.forename: S
authors.initials: S
authors.lastname: Romero-Steiner
authors.forename: C
authors.initials: C
authors.lastname: Rose
authors.forename: D
authors.initials: D
authors.lastname: Schmidt
authors.forename: J
authors.initials: J
authors.lastname: Stapleton
authors.forename: G M
authors.initials: GM
authors.lastname: Carlone
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods / Q000592:standards*; D006805:Human Experimentation; D006801:Humans; D022242:Pneumococcal Vaccines / Q000008:administration & dosage; D012015:Reference Standards; D013296:Streptococcus pneumoniae / Q000276:immunology*
chemical_list: C414006:23-valent pneumococcal capsular polysaccharide vaccine; D000907:Antibodies, Bacterial; D022242:Pneumococcal Vaccines